An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with numerous of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before directing customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Professionals Voice Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.
Several professionals said the popularity for retatrutide could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Removal
According to TikTok, the platform has taken down violative content and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the service safe and investing in strengthening compliance measures.
Online Marketplace Activities
Investigations also found communities with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, positive reviews and step-by-step instructions for preparing or administering at residence.
Within moments of joining one community, a vendor shared contact information, where most purchases occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Item Details and Pricing
Inside these communities, messages show dark colored parcels with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram said it actively monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.
Her team has already seen individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to potentially significant health risks”.
